ArticleBreast cancer (Tokyo, Japan)2025

Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters.

Keiko Natori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.